Search - Prime Therapeutics
Navigate to
-
Maryam Tabatabai, PharmD, associate vice president of clinical information, offers predictions about forthcoming drug approvals, the latest on a new voucher pilot, updated biosimilar guidance and more
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Perspectives -
What to expect at Academy of Managed Care Pharmacy (AMCP) Nexus 2023
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Stories -
Live updates from AMCP Annual Meeting
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Stories -
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...
PA Sub-Categories: GLP-1 Technology Specialty drugs Products Prime Article: Perspectives -
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.
PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases -
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases -
Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...
PA Sub-Categories: Specialty drugs Prime Article: Stories